Regulation of ACE2 and ANG-(1-7) in the aorta: New insights into the renin-angiotensin system in the control of vascular function

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 3 58-3, 2005, Pages

  Dantas, Ana Paula V ^a   Sandberg, Kathryn ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN[1-7]; COMPLEMENTARY DNA; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY COMPLIANCE; BLOOD PRESSURE REGULATION; BLOOD VESSEL FUNCTION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA LIBRARY; EDITORIAL; ELECTROLYTE BALANCE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HYPERTENSION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM RETENTION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WATER RETENTION;

ANGIOTENSIN I; ANIMALS; AORTA; CARBOXYPEPTIDASES; CARDIOVASCULAR DISEASES; HUMANS; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM;

EID: 23944500794     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00476.2005     Document Type: Editorial

References (24)

1. Burrell LM, Johnston CI, Tikellis C, and Cooper ME. ACE2. a new regulator of the renin-angiotensin system. Trends Endocrinol Metab 15: 166-169, 2004.
2. 2 receptor comes of age. Hypertension 45: 840-844, 2005.
3. Chappell MC, Gomez MN, Pirro NT, and Ferrario CM. Release of angiotensin-(l-V) from the rat hindlimb: influence of angiotensin-converting enzyme inhibition. Hypertension 35: 348-352, 2000.
4. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y, and Penninger JM. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417: 822-828, 2002.
5. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, and Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin 1 to angiotensin 1-9. Circ Res 87: E1-E9, 2000.
6. Ferrario CM. Angiotensin (1-7) and antihypertensive mechanisms. J Nephrol 11: 278-283, 1998.
7. Ferrario CM. The renin angiotensin system: importance in physiology and pathology. J Cardiovasc Pharmacol 15: S1-S5, 1990.
8. Ferreira AJ and Santos RAS. Cardiovascular action of angiotensin (1-7). Braz J Med Biol Res 38: 499-507, 2005.
9. Frohlich ED, Tarazi RC, and Dustan HP. Re-examination of the hemodynamics of hypertension. Am J Med Sci 257: 9-23, 1969.
10. Hundley WG, Kitzman DW, Morgan TM, Hamilton CA, Darty SN, Stewart KP, Herrington DM, Link KM, and Little WC. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 38: 796-802, 2001.
11. 1 receptors regulate ACE2 and angiotensin-(1-7) expression in aorta of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 289: H1013-H1019, 2005.
12. Li Q, Feenstra M, Pfaffendorf M, Eijsman L, and Van Zwieten PA. Comparative vasoconstrictor effects of angiotensin II, III, IV in humans isolated saphenous vein. J Cardiovasc Pharmacol 29: 451-456, 1997.
13. London GM. Large artery function and alterations in hypertension. J Hypertens Suppl 13: S35-S38, 1995.
14. Matsumoto Y, Hamada M, and Hiwada K. Aortic distensibility is closely related to the progression of left ventricular hypertrophy in patients receiving hemodialysis. Angiology 51: 933-941, 2000.
15. Mitchell GF. Increased aortic stiffness: an unfavorable cardiorenal connection. Hypertension 43: 151-153, 2004.
16. Morishita R, Higaki J, Nakamura F, Tomita N, Yu H, Nagano M, Mikami H, and Ogihara T. Regression of hypertension-induced vascular hypertrophy by an ACE inhibitor and calcium antagonist in the spontaneously hypertensive rat. Blood Press 3: 41-47, 1992.
17. Nicholls MG, Richards AM, and Agarwal M. The importance of the renin-angiotensin system in cardiovascular disease. J Hum Hypertens 12: 295-299, 1998.
18. Safar ME, London GM, Asmar R, and Frohlich ED. Recent advances on large arteries in hypertension. Hypertension 32: 156-161, 1998.
19. Santos RAS. Angiotensin (1-7): an update. Regul Pept 91: 45-62, 2000.
20. Savolainen A, Keto P, Poutanen VP, Hekali P, Standertskjold-Nordenstam CG, Rames A, and Kupari M. Effects of angiotensin-converting enzyme inhibition versus beta-adrenergic blockade on aortic stiffness in essential hypertension. J Cardiovasc Pharmacol 27: 99-104, 1996.
21. Stegbauer J, Vonend O, Oberhauser V, and Rump LC. Effects of angiotensin-(1-7) and other bioactive components of the renin-angiotensin system on vascular resistance and noradrenaline release in rat kidney. J Hypertens 21: 1391-1399, 2003.
22. Tom B, Dendorfer A, and Danser AH. Bradykinin, angiotensi (1-7), and ACE inhibitors: how do they interact? Int J Biochem Cell Biol 35: 792-801, 2003.
23. Touyz RM and Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 35: 1001-1015, 2003.
24. 1 receptor antagonists. Curr Med Chem Cardiovasc Hematol Agents 2: 69-77, 2004.